PL2352389T3 - Bifidobacterium longum - Google Patents
Bifidobacterium longumInfo
- Publication number
- PL2352389T3 PL2352389T3 PL09753220T PL09753220T PL2352389T3 PL 2352389 T3 PL2352389 T3 PL 2352389T3 PL 09753220 T PL09753220 T PL 09753220T PL 09753220 T PL09753220 T PL 09753220T PL 2352389 T3 PL2352389 T3 PL 2352389T3
- Authority
- PL
- Poland
- Prior art keywords
- bifidobacterium longum
- longum
- bifidobacterium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
- A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
- A23C19/061—Addition of, or treatment with, microorganisms
- A23C19/062—Addition of, or treatment with, microorganisms using only lactic acid bacteria, e.g. pediococcus, leconostoc or bifidus sp., or propionic acid bacteria; Treatment with non-specified acidifying bacterial cultures
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11351308P | 2008-11-11 | 2008-11-11 | |
| US14998009P | 2009-02-04 | 2009-02-04 | |
| PCT/IE2009/000079 WO2010055499A2 (en) | 2008-11-11 | 2009-11-11 | Bifidobacterium longum |
| EP09753220.4A EP2352389B1 (en) | 2008-11-11 | 2009-11-11 | Bifidobacterium longum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2352389T3 true PL2352389T3 (pl) | 2016-07-29 |
Family
ID=41572466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09753220T PL2352389T3 (pl) | 2008-11-11 | 2009-11-11 | Bifidobacterium longum |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9771624B2 (pl) |
| EP (1) | EP2352389B1 (pl) |
| CN (1) | CN102984955B (pl) |
| AU (1) | AU2009315298A1 (pl) |
| BR (1) | BRPI0921758A2 (pl) |
| CA (3) | CA2852487C (pl) |
| ES (1) | ES2566496T3 (pl) |
| MX (4) | MX356598B (pl) |
| PL (1) | PL2352389T3 (pl) |
| RU (1) | RU2570557C2 (pl) |
| WO (1) | WO2010055499A2 (pl) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2466185C2 (ru) * | 2007-03-28 | 2012-11-10 | Элиментари Хелт Лимитед | ПРОБИОТИЧЕСКИЙ ШТАММ Bifidobacterium longum, ПРОБИОТИЧЕСКАЯ КОМПОЗИЦИЯ И ПРИМЕНЕНИЯ ШТАММА Bifidobacterium longum |
| CN102984955B (zh) | 2008-11-11 | 2015-01-07 | 营养健康有限公司 | 长双歧杆菌 |
| EP2283810A1 (en) | 2009-07-16 | 2011-02-16 | University College Cork-National University of Ireland, Cork | Orally administered bacteria as vehicles for systemic delivery of agents |
| RU2546251C2 (ru) | 2009-11-11 | 2015-04-10 | Алиментари Хелс Лимитед | Пробиотический штамм бифидобактерий |
| JP5600179B2 (ja) * | 2009-11-11 | 2014-10-01 | アリメンタリー、ヘルス、リミテッド | ビフィズス菌株 |
| US9259019B2 (en) | 2010-11-11 | 2016-02-16 | Mars, Incorporated | Bifidobacteriumstrain |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
| US12279989B2 (en) | 2011-02-04 | 2025-04-22 | Seed Health, Inc. | Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity |
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US12257272B2 (en) | 2015-12-24 | 2025-03-25 | Seed Health, Inc. | Method and system for reducing the likelihood of developing depression in an individual |
| US12533312B2 (en) | 2011-02-04 | 2026-01-27 | Seed Health, Inc. | Method and system for preventing sore throat in humans |
| WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
| US9161957B2 (en) | 2012-08-03 | 2015-10-20 | Life Well Lived, Llc | Compositions and methods for reducing blood alcohol content |
| US10760064B2 (en) | 2013-03-15 | 2020-09-01 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
| WO2014204578A1 (en) | 2013-06-21 | 2014-12-24 | The General Hospital Corporation | Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing |
| US10378027B2 (en) | 2013-03-15 | 2019-08-13 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
| CN106459995B (zh) | 2013-11-07 | 2020-02-21 | 爱迪塔斯医药有限公司 | 使用统治型gRNA的CRISPR相关方法和组合物 |
| WO2015074054A1 (en) * | 2013-11-18 | 2015-05-21 | The Trustees Of Columbia University In The City Of New York | Improving microbial fitness in the mammalian gut |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US12329783B2 (en) | 2013-12-20 | 2025-06-17 | Seed Health, Inc. | Method and system to improve the health of a person's skin microbiome |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US10716816B2 (en) | 2014-10-24 | 2020-07-21 | Evolve Biosystems Inc. | Activated bifidobacteria and methods of use thereof |
| CA2964480A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| WO2016176380A1 (en) | 2015-04-28 | 2016-11-03 | The Procter & Gamble Company | Compositions comprising whole, non-viable micrococcus for improving skin health |
| CN104894005B (zh) * | 2015-04-30 | 2018-05-22 | 江苏紫石微康生物科技有限公司 | 一种高产胞外多糖的乳酸菌bl21及制备方法和应用 |
| RU2614116C2 (ru) * | 2015-07-21 | 2017-03-22 | Головин Михаил Анатольевич | Способ получения пробиотической композиции |
| EP3341081B1 (en) * | 2015-08-27 | 2020-11-11 | PrecisionBiotics Group Limited | Use of bifidobacterium longum and an exopolysaccharide produced thereby |
| CN108135946A (zh) * | 2015-08-27 | 2018-06-08 | 宝洁公司 | 长双歧杆菌 |
| US9926546B2 (en) | 2015-08-28 | 2018-03-27 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
| US9512446B1 (en) | 2015-08-28 | 2016-12-06 | The General Hospital Corporation | Engineered CRISPR-Cas9 nucleases |
| CN109069552B (zh) * | 2015-12-11 | 2023-01-24 | 精密生物集团有限公司 | 用于治疗肥胖症和相关代谢病的长双歧杆菌 |
| CN105907682A (zh) * | 2016-05-31 | 2016-08-31 | 深圳先进技术研究院 | 一种产高粘性多糖的细菌的筛选方法 |
| WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
| KR20250021602A (ko) | 2018-01-29 | 2025-02-13 | 프리시젼바이오틱스 그룹 리미티드 | 과민성 대장 증후군의 예방 및 치료를 위한 조합 생성물 |
| CN111902154A (zh) * | 2018-01-29 | 2020-11-06 | 精密生物集团有限公司 | 长双歧杆菌ncimb 41676 |
| WO2019145574A1 (en) * | 2018-01-29 | 2019-08-01 | Alimentary Health Limited | Bifidobacterium longum ncimb 41676 |
| US11771723B2 (en) | 2018-01-29 | 2023-10-03 | Precisionbiotics Group Limited | Bifidobacterium longum NCIMB 41676 |
| ES3056738T3 (en) * | 2018-01-29 | 2026-02-24 | Prec Group Limited | Bifidobacterium longum for improving sleep quality |
| US20210299193A1 (en) | 2018-07-13 | 2021-09-30 | Council Of Scientific & Industrial Research | Synbiotic composition for improving immune response and antioxidant capacity during aging and a process for the preparation thereof |
| JP7811843B2 (ja) | 2018-07-19 | 2026-02-06 | ペンデュラム セラピューティクス， インコーポレイテッド | 微生物生着のための方法および組成物 |
| CN114728028A (zh) * | 2019-04-17 | 2022-07-08 | 纽泰克温图斯公司 | 包括具有增强的持久性的新微生物的组合物、新微生物和益生元的协同组合 |
| CN110205393B (zh) * | 2019-07-03 | 2020-07-24 | 南京先声医学检验有限公司 | 用于检测营养代谢能力相关snp位点的引物组、应用、产品及方法 |
| JP7013419B2 (ja) * | 2019-08-07 | 2022-02-15 | 日清食品ホールディングス株式会社 | 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌 |
| WO2021077543A1 (zh) * | 2019-10-23 | 2021-04-29 | 江南大学 | 一种亚油酸异构酶及其在共轭亚油酸生产中的应用 |
| CN112391484B (zh) * | 2020-11-17 | 2022-12-27 | 江南大学 | 一种定量检测长双歧杆菌菌株的方法 |
| US20250312388A1 (en) * | 2022-01-12 | 2025-10-09 | Tahmeed Ahmed | Bifidobacterium infantis formulations |
| CN114507649B (zh) * | 2022-02-16 | 2023-11-21 | 吉林大学 | 嗜热酶及一锅法高效合成udp-葡萄糖和udp-葡萄糖醛酸的方法 |
| CN114774335B (zh) * | 2022-06-22 | 2022-09-02 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 具有靶向葡萄糖激酶显著降血糖和降血脂功效的长双歧杆菌070103及其应用 |
| CN117568301B (zh) * | 2023-11-16 | 2024-05-10 | 安徽农业大学 | 一种通过糖多孢红霉菌sace_1646基因提高红霉素产量的方法 |
| CN118086539B (zh) * | 2024-03-05 | 2024-10-01 | 中国食品发酵工业研究院有限公司 | 长双歧杆菌婴儿亚种的PMA-qPCR活菌定量检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| US20010049115A1 (en) * | 2000-01-17 | 2001-12-06 | Collins John Kevin | Vitro model for gastrointestinal inflammation |
| EP1227152A1 (en) * | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Bacterial strain and genome of bifidobacterium |
| AU2007216461B2 (en) * | 2006-02-15 | 2012-08-30 | Société des Produits Nestlé S.A. | Use of bifidobacterium longum for the prevention and treatment of inflammation |
| RU2333655C2 (ru) * | 2006-07-26 | 2008-09-20 | Государственное образовательное учреждение высшего профессионального образования Восточно-Сибирский государственный технологический университет | Способ получения селенсодержащей биологически активной добавки |
| EP2318513B1 (en) * | 2008-07-11 | 2012-09-19 | Chr. Hansen A/S | New probiotic bifidobacterium longum |
| CN102984955B (zh) | 2008-11-11 | 2015-01-07 | 营养健康有限公司 | 长双歧杆菌 |
-
2009
- 2009-11-11 CN CN200980145029.6A patent/CN102984955B/zh active Active
- 2009-11-11 MX MX2016005358A patent/MX356598B/es unknown
- 2009-11-11 EP EP09753220.4A patent/EP2352389B1/en active Active
- 2009-11-11 CA CA2852487A patent/CA2852487C/en active Active
- 2009-11-11 BR BRPI0921758A patent/BRPI0921758A2/pt not_active Application Discontinuation
- 2009-11-11 MX MX2016005356A patent/MX349706B/es unknown
- 2009-11-11 AU AU2009315298A patent/AU2009315298A1/en not_active Abandoned
- 2009-11-11 PL PL09753220T patent/PL2352389T3/pl unknown
- 2009-11-11 RU RU2011120271/10A patent/RU2570557C2/ru active
- 2009-11-11 ES ES09753220.4T patent/ES2566496T3/es active Active
- 2009-11-11 US US12/616,752 patent/US9771624B2/en not_active Expired - Fee Related
- 2009-11-11 MX MX2016005357A patent/MX349705B/es unknown
- 2009-11-11 MX MX2011005006A patent/MX339907B/es active IP Right Grant
- 2009-11-11 CA CA2852479A patent/CA2852479C/en active Active
- 2009-11-11 WO PCT/IE2009/000079 patent/WO2010055499A2/en not_active Ceased
- 2009-11-11 CA CA2741942A patent/CA2741942C/en active Active
-
2017
- 2017-08-23 US US15/683,805 patent/US10689719B2/en active Active
-
2020
- 2020-05-12 US US16/872,610 patent/US20200377961A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2852487A1 (en) | 2010-05-20 |
| CA2852479A1 (en) | 2010-05-20 |
| US20180016647A1 (en) | 2018-01-18 |
| MX349705B (es) | 2017-08-09 |
| US10689719B2 (en) | 2020-06-23 |
| MX349706B (es) | 2017-08-09 |
| BRPI0921758A2 (pt) | 2019-07-30 |
| AU2009315298A1 (en) | 2010-05-20 |
| CA2741942C (en) | 2018-01-16 |
| MX339907B (es) | 2016-06-14 |
| CN102984955A (zh) | 2013-03-20 |
| US9771624B2 (en) | 2017-09-26 |
| CN102984955B (zh) | 2015-01-07 |
| CA2741942A1 (en) | 2010-05-20 |
| US20100183559A1 (en) | 2010-07-22 |
| EP2352389A2 (en) | 2011-08-10 |
| US20200377961A1 (en) | 2020-12-03 |
| WO2010055499A3 (en) | 2010-09-23 |
| ES2566496T3 (es) | 2016-04-13 |
| WO2010055499A2 (en) | 2010-05-20 |
| CA2852479C (en) | 2017-01-24 |
| RU2011120271A (ru) | 2012-12-20 |
| MX2011005006A (es) | 2011-05-24 |
| MX356598B (es) | 2018-06-04 |
| EP2352389B1 (en) | 2016-01-06 |
| RU2570557C2 (ru) | 2015-12-10 |
| CA2852487C (en) | 2017-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2460781B (en) | Probiotic bifidobacterium strains | |
| GB2465051B (en) | Probiotic bifidobacterium strains | |
| PL2498789T3 (pl) | Probiotyczny szczep bifidobacterium | |
| ZA201202155B (en) | Bifidobacterium longum and functional gi disorders | |
| EG25742A (en) | Photobioreactor | |
| DK2318513T3 (da) | Ny probiotisk bifidobacterium longum | |
| GB2504633B (en) | Nanoemulsions | |
| ZA201007327B (en) | Synbiotic mixture | |
| EP2262589A4 (en) | CYCLONE | |
| PL2103827T3 (pl) | Połączenia wał-piasta | |
| GB0812597D0 (en) | Modified surfaces | |
| GB0814573D0 (en) | Photobioreactors | |
| GB0913505D0 (en) | Differential | |
| EP2317180A4 (de) | Abik-differential | |
| PL380803A1 (pl) | Nowy szczep Bifidobacterium longum | |
| GB0807264D0 (en) | Biocontrol | |
| GB0810722D0 (en) | mesher | |
| GB0808074D0 (en) | P2 | |
| GB0804838D0 (en) | Concept six | |
| GB0805454D0 (en) | Concept eight | |
| GB0811149D0 (en) | Gene | |
| GB0817884D0 (en) | Technology predction | |
| GB201108463D0 (en) | Nanoemulsions | |
| GB0804837D0 (en) | Concept three | |
| HU0800039V0 (en) | Construction set |